Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi

New Delhi: The Delhi Drugs Control Department seized medicines worth around ₹14 lakh from an unlicensed residential premises in Madipur village here and arrested one person, officials said on Wednesday.

In separate inspections, officials said they found violations at 37 of 62 drug establishments across the city.

According to the official statement, the Delhi Drugs Control Department and the Delhi Police Crime Branch seized medicines suspected to be of doubtful quality, allegedly stocked for sale and distribution without a valid licence, during a joint operation on November 4 and 5.

A drugs inspector seized the stock under the Drugs and Cosmetics Act, 1940, and collected samples for laboratory testing. Officials said the department is initiating legal proceedings against those involved.

In a separate enforcement drive targeting the unauthorised sale of antibiotics and prescription medicines, officials inspected 62 retail and wholesale drug establishments, of which 37 were found violating statutory requirements.

Of the 41 establishments officials inspected in Krishna Nagar, GTB Nagar and Rohini, they found violations at 25. These included selling medicines without a registered pharmacist present, inadequate maintenance of purchase and sale records, and dispensing prescription drugs without valid prescriptions.

At 12 of the 21 establishments inspected near AIIMS and Safdarjung Hospital, officials found violations.

They also collected 110 drug samples for quality testing.

The inspections covered the unauthorised sale of medical termination of pregnancy kits and compliance with requirements for installing CCTV cameras. Officials have issued show-cause notices to the establishments found violating the rules, and further action will be taken in accordance with the law, the Delhi Drugs Control Department said.

The department said the indiscriminate use of antibiotics and their sale without valid prescriptions contribute to antimicrobial resistance, making infections increasingly difficult to treat.

“Medicines must be sourced, stored and sold strictly in accordance with the law. Antibiotics cannot be treated as ordinary over-the-counter products. Every unauthorised sale puts patients at risk and contributes to the growing threat of antimicrobial resistance,” Rajeev Bhargav, licensing authority and head of the department’s office, said.

He said pharmacists and drug retailers had an important responsibility to safeguard public health and violations would invite strict action.

The department said inspections, surprise checks, and sampling drives would continue across Delhi, focusing on unlicensed drug operations and the unauthorised sale of prescription medicines.

  • Related Posts

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    India’s pharmaceutical exporters have been offered a fresh business opportunity to expand their presence in Saudi Arabia, with Riyadh-based Al Hobail Medical Company seeking Indian manufacturing partners for the registration…

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    The restriction is intended to prevent manufacturers from using product names and promotional language that create an impression of medical efficacy without regulatory approval or scientific substantiation. Health supplements being…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    UP expands food, drug testing capacity across all 18 divisions

    UP expands food, drug testing capacity across all 18 divisions

    Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

    Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

    Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi

    Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi

    Cepheid achieves CE marking under IVDR for Xpert Respiratory Panel

    Cepheid achieves CE marking under IVDR for Xpert Respiratory Panel